CELC (STOCKS)
Celcuity Inc. Common Stock
$119.140000
+2.000000 (+1.71%)
Prev close: $117.140000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Brian F. Sullivan
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $5,824.57M
- Employees
- 87
- P/E (TTM)
- -31.80
- P/B (TTM)
- 57.77
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
7
Strong Buy
8
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-0.97 | $-1.06 | +0.0927 | +8.72% |
|
Sep 2025 (Q3)
|
$-0.92 | $-1.03 | +0.1089 | +10.58% |
|
Jun 2025 (Q2)
|
$-1.04 | $-0.90 | -0.1380 | -15.30% |
|
Mar 2025 (Q1)
|
$-0.86 | $-0.88 | +0.0189 | +2.15% |
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | -$4.85M |
| Operating Expenses | $172.19M |
| Research and Development | $145.00M |
| Other Operating Expenses | $27.20M |
| Operating Income/Loss | -$172.19M |
| Income/Loss From Continuing Operations After Tax | -$177.04M |
| Income/Loss From Continuing Operations Before Tax | -$177.04M |
| Net Income/Loss | -$177.04M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$177.04M |
| Net Income/Loss Available To Common Stockholders, Basic | -$177.04M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$3.79 |
| Diluted Earnings Per Share | -$3.79 |
| Basic Average Shares | 46,757,691 |
| Diluted Average Shares | 46,757,691 |
| Assets | $466.56M |
| Current Assets | $465.66M |
| Noncurrent Assets | $899.00K |
| Fixed Assets | $499.00K |
| Other Non-current Assets | $400.00K |
| Liabilities | $366.00M |
| Current Liabilities | $44.15M |
| Accounts Payable | $6.41M |
| Other Current Liabilities | $37.75M |
| Noncurrent Liabilities | $321.85M |
| Long-term Debt | $137.55M |
| Other Non-current Liabilities | $184.30M |
| Equity | $100.56M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $100.56M |
| Liabilities And Equity | $466.56M |
| Net Cash Flow From Operating Activities | -$153.28M |
| Net Cash Flow From Operating Activities, Continuing | -$153.28M |
| Net Cash Flow From Investing Activities | -$64.08M |
| Net Cash Flow From Investing Activities, Continuing | -$64.08M |
| Net Cash Flow From Financing Activities | $360.55M |
| Net Cash Flow From Financing Activities, Continuing | $360.55M |
| Net Cash Flow | $143.19M |
| Net Cash Flow, Continuing | $143.19M |
| Comprehensive Income/Loss | -$177.04M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$177.04M |
| Other Comprehensive Income/Loss | $0.00 |